| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | ATP8B3 MYH3 MYH6 MYH7 MYH13 HSP90AB4P ERCC6L RBBP4 RHOBTB3 CCT7 MYO1B MCM6 MSH6 MYH15 ATP12A DDX21 DNAH11 | 7.12e-09 | 614 | 98 | 17 | GO:0140657 |
| GeneOntologyMolecularFunction | MAP kinase activity | 1.07e-08 | 16 | 98 | 5 | GO:0004707 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 2.91e-08 | 38 | 98 | 6 | GO:0000146 | |
| GeneOntologyMolecularFunction | JUN kinase activity | 1.15e-07 | 3 | 98 | 3 | GO:0004705 | |
| GeneOntologyMolecularFunction | actin filament binding | 1.73e-07 | 227 | 98 | 10 | GO:0051015 | |
| GeneOntologyMolecularFunction | actin binding | MYH3 MYH6 MYH7 MYH13 SYNE1 MYO1B ACTN1 ACTN3 DST SYNE2 TAGLN3 MYH15 TAGLN | 6.22e-07 | 479 | 98 | 13 | GO:0003779 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.87e-06 | 118 | 98 | 7 | GO:0003774 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ATP8B3 MYH3 MYH7 HSP90AB4P ERCC6L RHOBTB3 CCT7 MCM6 ATP12A DDX21 DNAH11 | 1.07e-05 | 441 | 98 | 11 | GO:0016887 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYH3 MYH6 MYH7 MYH13 SYNE1 APC2 MYO1B ACTN1 ACTN3 OPA1 KIFAP3 DST SYNE2 TAGLN3 MYH15 TAGLN MAPK8 | 2.30e-05 | 1099 | 98 | 17 | GO:0008092 |
| GeneOntologyMolecularFunction | protein serine/threonine/tyrosine kinase activity | 8.28e-05 | 47 | 98 | 4 | GO:0004712 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein-specific endopeptidase activity | 2.36e-04 | 5 | 98 | 2 | GO:0070137 | |
| GeneOntologyMolecularFunction | SUMO-specific endopeptidase activity | 2.36e-04 | 5 | 98 | 2 | GO:0070139 | |
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 2.36e-04 | 5 | 98 | 2 | GO:0140444 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ATP8B3 MYH3 MYH7 HSP90AB4P ERCC6L RHOBTB3 CCT7 MCM6 OPA1 ATP12A DDX21 DNAH11 | 4.09e-04 | 775 | 98 | 12 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ATP8B3 MYH3 MYH7 HSP90AB4P ERCC6L RHOBTB3 CCT7 MCM6 OPA1 ATP12A DDX21 DNAH11 | 8.23e-04 | 839 | 98 | 12 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ATP8B3 MYH3 MYH7 HSP90AB4P ERCC6L RHOBTB3 CCT7 MCM6 OPA1 ATP12A DDX21 DNAH11 | 8.32e-04 | 840 | 98 | 12 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ATP8B3 MYH3 MYH7 HSP90AB4P ERCC6L RHOBTB3 CCT7 MCM6 OPA1 ATP12A DDX21 DNAH11 | 8.32e-04 | 840 | 98 | 12 | GO:0016818 |
| GeneOntologyMolecularFunction | calmodulin binding | 9.53e-04 | 230 | 98 | 6 | GO:0005516 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | ERCC6L RBBP4 MCM6 MSH6 METTL5 PUS10 DDX21 NOP2 DNASE1L3 TGS1 | 1.26e-03 | 645 | 98 | 10 | GO:0140640 |
| GeneOntologyMolecularFunction | histone chaperone activity | 2.40e-03 | 15 | 98 | 2 | GO:0140713 | |
| GeneOntologyBiologicalProcess | DNA replication-dependent chromatin assembly | 2.06e-06 | 6 | 98 | 3 | GO:0006335 | |
| GeneOntologyBiologicalProcess | muscle cell differentiation | MYH3 MYH6 MYH7 SYNE1 KLHL40 ACTN1 ACTN3 MYOF MAPK14 EPC1 MAPK11 ASF1A | 8.14e-06 | 531 | 98 | 12 | GO:0042692 |
| GeneOntologyBiologicalProcess | response to UV | 1.50e-05 | 167 | 98 | 7 | GO:0009411 | |
| GeneOntologyBiologicalProcess | cellular senescence | 3.35e-05 | 128 | 98 | 6 | GO:0090398 | |
| GeneOntologyBiologicalProcess | muscle filament sliding | 4.54e-05 | 15 | 98 | 3 | GO:0030049 | |
| GeneOntologyBiologicalProcess | regulation of the force of skeletal muscle contraction | 6.68e-05 | 3 | 98 | 2 | GO:0014728 | |
| GeneOntologyBiologicalProcess | regulation of skeletal muscle contraction by chemo-mechanical energy conversion | 6.68e-05 | 3 | 98 | 2 | GO:0014862 | |
| GeneOntologyBiologicalProcess | actin-myosin filament sliding | 8.06e-05 | 18 | 98 | 3 | GO:0033275 | |
| GeneOntologyBiologicalProcess | response to light stimulus | 8.60e-05 | 382 | 98 | 9 | GO:0009416 | |
| GeneOntologyBiologicalProcess | regulation of cell fate commitment | 1.17e-04 | 53 | 98 | 4 | GO:0010453 | |
| GeneOntologyBiologicalProcess | DNA replication | 1.21e-04 | 312 | 98 | 8 | GO:0006260 | |
| GeneOntologyBiologicalProcess | response to UV-B | 1.30e-04 | 21 | 98 | 3 | GO:0010224 | |
| GeneOntologyBiologicalProcess | protein localization to tricellular tight junction | 1.33e-04 | 4 | 98 | 2 | GO:0061833 | |
| GeneOntologyBiologicalProcess | muscle structure development | MYH3 MYH6 MYH7 SYNE1 KLHL40 ACTN1 ACTN3 MYOF MAPK14 EPC1 TAGLN MAPK11 ASF1A | 2.09e-04 | 858 | 98 | 13 | GO:0061061 |
| GeneOntologyBiologicalProcess | regulation of twitch skeletal muscle contraction | 2.21e-04 | 5 | 98 | 2 | GO:0014724 | |
| GeneOntologyBiologicalProcess | Fc-epsilon receptor signaling pathway | 2.22e-04 | 25 | 98 | 3 | GO:0038095 | |
| GeneOntologyBiologicalProcess | muscle cell development | 2.38e-04 | 259 | 98 | 7 | GO:0055001 | |
| GeneOntologyCellularComponent | myofibril | MYH3 MYH6 MYH7 MYH13 SYNE1 KLHL40 STYXL2 ACTN1 ACTN3 DST SYNE2 MYH15 | 7.32e-09 | 273 | 100 | 12 | GO:0030016 |
| GeneOntologyCellularComponent | contractile muscle fiber | MYH3 MYH6 MYH7 MYH13 SYNE1 KLHL40 STYXL2 ACTN1 ACTN3 DST SYNE2 MYH15 | 1.44e-08 | 290 | 100 | 12 | GO:0043292 |
| GeneOntologyCellularComponent | myosin filament | 1.12e-07 | 25 | 100 | 5 | GO:0032982 | |
| GeneOntologyCellularComponent | supramolecular fiber | MYH3 MYH6 MYH7 MYH13 SYNE1 KLHL40 APC2 STYXL2 CCT7 MYO1B ACTN1 ACTN3 OPA1 KIFAP3 MFAP1 TEKT2 DST SYNE2 MYH15 ARHGAP18 DNAH11 | 1.43e-07 | 1179 | 100 | 21 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | MYH3 MYH6 MYH7 MYH13 SYNE1 KLHL40 APC2 STYXL2 CCT7 MYO1B ACTN1 ACTN3 OPA1 KIFAP3 MFAP1 TEKT2 DST SYNE2 MYH15 ARHGAP18 DNAH11 | 1.60e-07 | 1187 | 100 | 21 | GO:0099081 |
| GeneOntologyCellularComponent | myosin II complex | 2.04e-07 | 28 | 100 | 5 | GO:0016460 | |
| GeneOntologyCellularComponent | sarcomere | 3.25e-07 | 249 | 100 | 10 | GO:0030017 | |
| GeneOntologyCellularComponent | myosin complex | 3.78e-07 | 59 | 100 | 6 | GO:0016459 | |
| GeneOntologyCellularComponent | muscle myosin complex | 8.58e-07 | 16 | 100 | 4 | GO:0005859 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH3 MYH6 MYH7 MYH13 APC2 MYO1B ACTN1 ACTN3 DST TAGLN3 MYH15 ATP12A MAPK8 | 3.66e-06 | 576 | 100 | 13 | GO:0015629 |
| GeneOntologyCellularComponent | I band | 1.51e-05 | 166 | 100 | 7 | GO:0031674 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | THEMIS GNL3L ACTR5 RBBP4 ORC6 RBBP7 SYNE1 MCM6 HEATR1 FANCB MSH6 MFAP1 CRNKL1 PRDM8 SYNE2 MPHOSPH6 DDX21 TGS1 | 8.48e-05 | 1377 | 100 | 18 | GO:0140513 |
| GeneOntologyCellularComponent | Z disc | 8.77e-05 | 151 | 100 | 6 | GO:0030018 | |
| GeneOntologyCellularComponent | lamellipodium membrane | 1.53e-04 | 22 | 100 | 3 | GO:0031258 | |
| GeneOntologyCellularComponent | NURF complex | 4.68e-04 | 7 | 100 | 2 | GO:0016589 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 1.17e-03 | 96 | 100 | 4 | GO:0070603 | |
| GeneOntologyCellularComponent | microtubule organizing center attachment site | 1.21e-03 | 11 | 100 | 2 | GO:0034992 | |
| GeneOntologyCellularComponent | meiotic nuclear membrane microtubule tethering complex | 1.21e-03 | 11 | 100 | 2 | GO:0034993 | |
| GeneOntologyCellularComponent | nuclear membrane protein complex | 1.21e-03 | 11 | 100 | 2 | GO:0106083 | |
| GeneOntologyCellularComponent | nuclear membrane microtubule tethering complex | 1.21e-03 | 11 | 100 | 2 | GO:0106094 | |
| GeneOntologyCellularComponent | nuclear chromosome | 1.40e-03 | 254 | 100 | 6 | GO:0000228 | |
| GeneOntologyCellularComponent | contractile actin filament bundle | 1.75e-03 | 107 | 100 | 4 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 1.75e-03 | 107 | 100 | 4 | GO:0001725 | |
| GeneOntologyCellularComponent | ISWI-type complex | 1.99e-03 | 14 | 100 | 2 | GO:0031010 | |
| GeneOntologyCellularComponent | actomyosin | 2.42e-03 | 117 | 100 | 4 | GO:0042641 | |
| GeneOntologyCellularComponent | actin filament bundle | 2.49e-03 | 118 | 100 | 4 | GO:0032432 | |
| GeneOntologyCellularComponent | CHD-type complex | 2.94e-03 | 17 | 100 | 2 | GO:0090545 | |
| GeneOntologyCellularComponent | ESC/E(Z) complex | 2.94e-03 | 17 | 100 | 2 | GO:0035098 | |
| GeneOntologyCellularComponent | NuRD complex | 2.94e-03 | 17 | 100 | 2 | GO:0016581 | |
| GeneOntologyCellularComponent | pseudopodium | 3.30e-03 | 18 | 100 | 2 | GO:0031143 | |
| GeneOntologyCellularComponent | ATPase complex | 3.44e-03 | 129 | 100 | 4 | GO:1904949 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | APC2 CCT7 MYO1B ACTN1 ACTN3 OPA1 KIFAP3 TEKT2 DST ARHGAP18 DNAH11 | 3.79e-03 | 899 | 100 | 11 | GO:0099513 |
| GeneOntologyCellularComponent | microtubule | 4.06e-03 | 533 | 100 | 8 | GO:0005874 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 4.20e-03 | 317 | 100 | 6 | GO:0032838 | |
| GeneOntologyCellularComponent | Sin3-type complex | 4.92e-03 | 22 | 100 | 2 | GO:0070822 | |
| GeneOntologyCellularComponent | tertiary granule membrane | 5.18e-03 | 73 | 100 | 3 | GO:0070821 | |
| GeneOntologyCellularComponent | actin filament | 5.33e-03 | 146 | 100 | 4 | GO:0005884 | |
| Domain | MAP_kinase_CS | 2.91e-09 | 12 | 99 | 5 | IPR003527 | |
| Domain | MAPK | 2.91e-09 | 12 | 99 | 5 | PS01351 | |
| Domain | Myosin_N | 1.09e-08 | 15 | 99 | 5 | PF02736 | |
| Domain | Myosin_N | 1.09e-08 | 15 | 99 | 5 | IPR004009 | |
| Domain | Myosin_tail_1 | 3.07e-08 | 18 | 99 | 5 | PF01576 | |
| Domain | Myosin_tail | 3.07e-08 | 18 | 99 | 5 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 4.14e-08 | 19 | 99 | 5 | IPR027401 | |
| Domain | - | 4.14e-08 | 19 | 99 | 5 | 4.10.270.10 | |
| Domain | Myosin_head_motor_dom | 4.58e-08 | 38 | 99 | 6 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 4.58e-08 | 38 | 99 | 6 | PS51456 | |
| Domain | Myosin_head | 4.58e-08 | 38 | 99 | 6 | PF00063 | |
| Domain | MYSc | 4.58e-08 | 38 | 99 | 6 | SM00242 | |
| Domain | CH | 5.13e-08 | 65 | 99 | 7 | SM00033 | |
| Domain | CH | 8.65e-08 | 70 | 99 | 7 | PF00307 | |
| Domain | - | 9.56e-08 | 71 | 99 | 7 | 1.10.418.10 | |
| Domain | CH | 1.16e-07 | 73 | 99 | 7 | PS50021 | |
| Domain | Actinin_actin-bd_CS | 1.18e-07 | 23 | 99 | 5 | IPR001589 | |
| Domain | Spectrin | 1.18e-07 | 23 | 99 | 5 | PF00435 | |
| Domain | ACTININ_2 | 1.18e-07 | 23 | 99 | 5 | PS00020 | |
| Domain | ACTININ_1 | 1.18e-07 | 23 | 99 | 5 | PS00019 | |
| Domain | CH-domain | 1.40e-07 | 75 | 99 | 7 | IPR001715 | |
| Domain | Spectrin_repeat | 4.06e-07 | 29 | 99 | 5 | IPR002017 | |
| Domain | Spectrin/alpha-actinin | 6.79e-07 | 32 | 99 | 5 | IPR018159 | |
| Domain | SPEC | 6.79e-07 | 32 | 99 | 5 | SM00150 | |
| Domain | MAPK_JNK | 1.43e-06 | 5 | 99 | 3 | IPR008351 | |
| Domain | IQ | 1.00e-05 | 93 | 99 | 6 | PS50096 | |
| Domain | - | 2.78e-05 | 2 | 99 | 2 | 2.60.40.1490 | |
| Domain | ASF1_hist_chap | 2.78e-05 | 2 | 99 | 2 | PF04729 | |
| Domain | ASF1-like | 2.78e-05 | 2 | 99 | 2 | IPR006818 | |
| Domain | IQ | 7.04e-05 | 81 | 99 | 5 | SM00015 | |
| Domain | CAF1C_H4-bd | 8.32e-05 | 3 | 99 | 2 | PF12265 | |
| Domain | Histone-bd_RBBP4_N | 8.32e-05 | 3 | 99 | 2 | IPR022052 | |
| Domain | IQ_motif_EF-hand-BS | 1.16e-04 | 90 | 99 | 5 | IPR000048 | |
| Domain | P-loop_NTPase | MYH3 MYH6 MYH7 GNL3L MYH13 ERCC6L RHOBTB3 MYO1B MCM6 OPA1 MSH6 MYH15 DDX21 DNAH11 | 1.49e-04 | 848 | 99 | 14 | IPR027417 |
| Domain | KASH | 1.66e-04 | 4 | 99 | 2 | PF10541 | |
| Domain | KASH | 1.66e-04 | 4 | 99 | 2 | IPR012315 | |
| Domain | MAPK_p38 | 1.66e-04 | 4 | 99 | 2 | IPR008352 | |
| Domain | KASH | 1.66e-04 | 4 | 99 | 2 | PS51049 | |
| Domain | KASH | 1.66e-04 | 4 | 99 | 2 | SM01249 | |
| Domain | EF-hand_Ca_insen | 4.11e-04 | 6 | 99 | 2 | IPR014837 | |
| Domain | Calponin_repeat | 4.11e-04 | 6 | 99 | 2 | IPR000557 | |
| Domain | Calponin | 4.11e-04 | 6 | 99 | 2 | PF00402 | |
| Domain | CALPONIN_1 | 4.11e-04 | 6 | 99 | 2 | PS01052 | |
| Domain | CALPONIN_2 | 4.11e-04 | 6 | 99 | 2 | PS51122 | |
| Domain | EFhand_Ca_insen | 4.11e-04 | 6 | 99 | 2 | PF08726 | |
| Domain | IQ | 5.50e-04 | 71 | 99 | 4 | PF00612 | |
| Domain | Peptidase_C48 | 5.74e-04 | 7 | 99 | 2 | PF02902 | |
| Domain | TLV_coat | 5.74e-04 | 7 | 99 | 2 | PF00429 | |
| Domain | ULP_PROTEASE | 5.74e-04 | 7 | 99 | 2 | PS50600 | |
| Domain | Peptidase_C48_C | 5.74e-04 | 7 | 99 | 2 | IPR003653 | |
| Domain | TLV/ENV_coat_polyprotein | 7.63e-04 | 8 | 99 | 2 | IPR018154 | |
| Domain | SM22_calponin | 1.48e-03 | 11 | 99 | 2 | IPR003096 | |
| Pathway | REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE | 6.13e-10 | 37 | 72 | 7 | MM14899 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_AP_1_FAMILY_OF_TRANSCRIPTION_FACTORS | 7.46e-10 | 10 | 72 | 5 | MM15135 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_AP_1_FAMILY_OF_TRANSCRIPTION_FACTORS | 7.46e-10 | 10 | 72 | 5 | M13962 | |
| Pathway | REACTOME_CELLULAR_SENESCENCE | 1.55e-07 | 119 | 72 | 8 | MM14901 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR2_4_MAPK_SIGNALING_PATHWAY | 1.83e-07 | 26 | 72 | 5 | M47565 | |
| Pathway | WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING | 2.71e-07 | 28 | 72 | 5 | M39572 | |
| Pathway | REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES | 2.71e-07 | 28 | 72 | 5 | MM15132 | |
| Pathway | WP_CANNABINOID_RECEPTOR_SIGNALING | 3.26e-07 | 29 | 72 | 5 | M39676 | |
| Pathway | REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES | 4.63e-07 | 31 | 72 | 5 | M15195 | |
| Pathway | PID_CD40_PATHWAY | 4.63e-07 | 31 | 72 | 5 | M45 | |
| Pathway | SIG_CD40PATHWAYMAP | 7.49e-07 | 34 | 72 | 5 | M12705 | |
| Pathway | WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING | 1.01e-06 | 36 | 72 | 5 | M39908 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_VPR_TAT_TO_TNF_JNK_SIGNALING_PATHWAY | 1.27e-06 | 5 | 72 | 3 | M47570 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_PARAQUAT_TO_FAS_JNK_SIGNALING_PATHWAY | 1.27e-06 | 5 | 72 | 3 | M49021 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_TNF_JNK_SIGNALING_PATHWAY | 1.27e-06 | 5 | 72 | 3 | M49005 | |
| Pathway | PID_FAS_PATHWAY | 1.33e-06 | 38 | 72 | 5 | M94 | |
| Pathway | KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY | 1.58e-06 | 71 | 72 | 6 | M15913 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_TNF_JNK_SIGNALING_PATHWAY | 2.53e-06 | 6 | 72 | 3 | M47680 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_IRE1A_JNK_SIGNALING_PATHWAY | 2.53e-06 | 6 | 72 | 3 | M47698 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_DJ1_TO_FAS_JNK_SIGNALING_PATWHAY | 2.53e-06 | 6 | 72 | 3 | M47712 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_PTP | 2.85e-06 | 20 | 72 | 4 | M47928 | |
| Pathway | REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE | 3.33e-06 | 125 | 72 | 7 | M27186 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IRE1A_JNK_SIGNALING_PATHWAY | 4.41e-06 | 7 | 72 | 3 | M47697 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FAS_JNK_SIGNALING_PATHWAY | 4.41e-06 | 7 | 72 | 3 | M47711 | |
| Pathway | KEGG_TIGHT_JUNCTION | 4.78e-06 | 132 | 72 | 7 | M11355 | |
| Pathway | WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY | 4.83e-06 | 49 | 72 | 5 | M39543 | |
| Pathway | WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING | 5.15e-06 | 23 | 72 | 4 | M39709 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_JNK_SIGNALING_PATHWAY | 7.02e-06 | 8 | 72 | 3 | M47814 | |
| Pathway | REACTOME_CELLULAR_SENESCENCE | 7.03e-06 | 197 | 72 | 8 | M27188 | |
| Pathway | REACTOME_INTERLEUKIN_17_SIGNALING | 1.22e-05 | 59 | 72 | 5 | MM15128 | |
| Pathway | KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY | 1.31e-05 | 102 | 72 | 6 | M3261 | |
| Pathway | WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY | 1.33e-05 | 60 | 72 | 5 | M39583 | |
| Pathway | WP_TOLLLIKE_RECEPTOR_SIGNALING | 1.39e-05 | 103 | 72 | 6 | M39434 | |
| Pathway | REACTOME_ACTIVATION_OF_PPARGC1A_PGC_1ALPHA_BY_PHOSPHORYLATION | 1.49e-05 | 10 | 72 | 3 | M27146 | |
| Pathway | KEGG_COLORECTAL_CANCER | 1.56e-05 | 62 | 72 | 5 | M14631 | |
| Pathway | KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY | 1.56e-05 | 62 | 72 | 5 | M15569 | |
| Pathway | KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION | 2.45e-05 | 68 | 72 | 5 | M16848 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MLK_JNK_SIGNALING_PATHWAY | 2.72e-05 | 12 | 72 | 3 | M47929 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 2.82e-05 | 70 | 72 | 5 | M12294 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 3.02e-05 | 118 | 72 | 6 | M39852 | |
| Pathway | REACTOME_INTERLEUKIN_17_SIGNALING | 3.03e-05 | 71 | 72 | 5 | M27382 | |
| Pathway | WP_WNT_SIGNALING_IN_KIDNEY_DISEASE | 3.26e-05 | 36 | 72 | 4 | M39699 | |
| Pathway | WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER | 3.46e-05 | 73 | 72 | 5 | M39758 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_JNK_SIGNALING_PATHWAY | 3.52e-05 | 13 | 72 | 3 | M47594 | |
| Pathway | BIOCARTA_MAPK_PATHWAY | 4.21e-05 | 76 | 72 | 5 | MM1433 | |
| Pathway | WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING | 4.77e-05 | 78 | 72 | 5 | M39824 | |
| Pathway | KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY | 5.07e-05 | 79 | 72 | 5 | M11816 | |
| Pathway | WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY | 5.66e-05 | 132 | 72 | 6 | M39338 | |
| Pathway | BIOCARTA_MAPK_PATHWAY | 5.72e-05 | 81 | 72 | 5 | M13863 | |
| Pathway | PID_REG_GR_PATHWAY | 6.07e-05 | 82 | 72 | 5 | M115 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TNF_JNK_SIGNALING_PATHWAY | 6.82e-05 | 16 | 72 | 3 | M47569 | |
| Pathway | REACTOME_MYD88_MAL_TIRAP_CASCADE_INITIATED_ON_PLASMA_MEMBRANE | 7.21e-05 | 85 | 72 | 5 | MM14645 | |
| Pathway | KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION | 7.21e-05 | 85 | 72 | 5 | M3578 | |
| Pathway | WP_WNT_SIGNALING_IN_KIDNEY_DISEASE | 7.28e-05 | 44 | 72 | 4 | MM15878 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING | 8.25e-05 | 17 | 72 | 3 | M39686 | |
| Pathway | WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS | 8.68e-05 | 46 | 72 | 4 | M39805 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IL1_IL1R_JNK_SIGNALING_PATHWAY | 1.17e-04 | 19 | 72 | 3 | M47471 | |
| Pathway | REACTOME_TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE | 1.49e-04 | 99 | 72 | 5 | MM14660 | |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 1.63e-04 | 101 | 72 | 5 | M1979 | |
| Pathway | PID_IL2_1PATHWAY | 1.75e-04 | 55 | 72 | 4 | M122 | |
| Pathway | REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1 | 1.83e-04 | 22 | 72 | 3 | M859 | |
| Pathway | REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1 | 2.10e-04 | 23 | 72 | 3 | MM15134 | |
| Pathway | PID_ATF2_PATHWAY | 2.30e-04 | 59 | 72 | 4 | M166 | |
| Pathway | REACTOME_MYD88_INDEPENDENT_TLR4_CASCADE | 2.34e-04 | 109 | 72 | 5 | M29565 | |
| Pathway | REACTOME_TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE | 2.34e-04 | 109 | 72 | 5 | M27012 | |
| Pathway | WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART | 2.39e-04 | 24 | 72 | 3 | M39576 | |
| Pathway | PID_LYMPH_ANGIOGENESIS_PATHWAY | 2.71e-04 | 25 | 72 | 3 | M274 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_E2F6 | 2.71e-04 | 25 | 72 | 3 | MM15546 | |
| Pathway | REACTOME_TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE | 3.00e-04 | 115 | 72 | 5 | M27013 | |
| Pathway | PID_RB_1PATHWAY | 3.35e-04 | 65 | 72 | 4 | M279 | |
| Pathway | WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS | 3.51e-04 | 119 | 72 | 5 | M48309 | |
| Pathway | KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY | 3.76e-04 | 67 | 72 | 4 | M10462 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SHIGELLA_OSPF_TO_TLR2_4_MAPK_SIGNALING_PATHWAY | 3.81e-04 | 6 | 72 | 2 | M47766 | |
| Pathway | REACTOME_TOLL_LIKE_RECEPTOR_4_TLR4_CASCADE | 3.94e-04 | 122 | 72 | 5 | MM14640 | |
| Pathway | WP_RAC1PAK1P38MMP2_PATHWAY | 3.98e-04 | 68 | 72 | 4 | M39456 | |
| Pathway | PID_VEGFR1_2_PATHWAY | 4.21e-04 | 69 | 72 | 4 | M237 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_VGPCR_TO_GNB_G_PI3K_JNK_SIGNALING_PATHWAY | 4.24e-04 | 29 | 72 | 3 | M47466 | |
| Pathway | KEGG_NEUROTROPHIN_SIGNALING_PATHWAY | 4.57e-04 | 126 | 72 | 5 | M16763 | |
| Pathway | PID_NEPHRIN_NEPH1_PATHWAY | 5.18e-04 | 31 | 72 | 3 | M193 | |
| Pathway | KEGG_FOCAL_ADHESION | 5.29e-04 | 199 | 72 | 6 | M7253 | |
| Pathway | REACTOME_P38MAPK_EVENTS | 5.31e-04 | 7 | 72 | 2 | MM14672 | |
| Pathway | PID_WNT_NONCANONICAL_PATHWAY | 5.70e-04 | 32 | 72 | 3 | M23 | |
| Pathway | WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3 | 5.78e-04 | 75 | 72 | 4 | M39568 | |
| Pathway | BIOCARTA_INTEGRIN_PATHWAY | 6.82e-04 | 34 | 72 | 3 | M3342 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_E2F6 | 6.82e-04 | 34 | 72 | 3 | M27826 | |
| Pathway | REACTOME_STRIATED_MUSCLE_CONTRACTION | 7.44e-04 | 35 | 72 | 3 | MM15005 | |
| Pathway | REACTOME_STRIATED_MUSCLE_CONTRACTION | 8.08e-04 | 36 | 72 | 3 | M18647 | |
| Pathway | WP_NEOVASCULARIZATION_PROCESSES | 8.76e-04 | 37 | 72 | 3 | M39506 | |
| Pathway | BIOCARTA_DSP_PATHWAY | 9.05e-04 | 9 | 72 | 2 | M22032 | |
| Pathway | BIOCARTA_DSP_PATHWAY | 9.05e-04 | 9 | 72 | 2 | MM1554 | |
| Pathway | WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY | 9.48e-04 | 38 | 72 | 3 | M39549 | |
| Pathway | REACTOME_CELLULAR_RESPONSES_TO_STIMULI | 1.03e-03 | 505 | 72 | 9 | MM15548 | |
| Pathway | KEGG_WNT_SIGNALING_PATHWAY | 1.04e-03 | 151 | 72 | 5 | M19428 | |
| Pathway | WP_HEPATITIS_B_INFECTION | 1.04e-03 | 151 | 72 | 5 | M39801 | |
| Pathway | WP_RETINOBLASTOMA_GENE_IN_CANCER | 1.15e-03 | 90 | 72 | 4 | M39678 | |
| Pathway | REACTOME_TOLL_LIKE_RECEPTOR_CASCADES | 1.17e-03 | 155 | 72 | 5 | MM14665 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY | 1.23e-03 | 157 | 72 | 5 | MM15226 | |
| Pathway | WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING | 1.27e-03 | 42 | 72 | 3 | M39452 | |
| Pathway | WP_INSULIN_SIGNALING | 1.34e-03 | 160 | 72 | 5 | MM15956 | |
| Pathway | WP_INSULIN_SIGNALING | 1.34e-03 | 160 | 72 | 5 | M39482 | |
| Pubmed | p38 MAPK signalling cascades: ancient roles and new functions. | 4.32e-12 | 7 | 103 | 5 | 10878576 | |
| Pubmed | 3.62e-10 | 5 | 103 | 4 | 22935704 | ||
| Pubmed | 4.05e-10 | 14 | 103 | 5 | 12239168 | ||
| Pubmed | Lem2 is essential for cardiac development by maintaining nuclear integrity. | 4.96e-10 | 32 | 103 | 6 | 37067297 | |
| Pubmed | Codanin-1, mutated in the anaemic disease CDAI, regulates Asf1 function in S-phase histone supply. | 6.06e-10 | 15 | 103 | 5 | 22407294 | |
| Pubmed | 1.08e-09 | 6 | 103 | 4 | 11698270 | ||
| Pubmed | Activation of mitogen activated protein kinases via complement receptor type 2. | 2.52e-09 | 7 | 103 | 4 | 15603708 | |
| Pubmed | 2.52e-09 | 7 | 103 | 4 | 11468147 | ||
| Pubmed | A Novel MAPK phosphatase MKP-7 acts preferentially on JNK/SAPK and p38 alpha and beta MAPKs. | 5.03e-09 | 8 | 103 | 4 | 11359773 | |
| Pubmed | 5.23e-09 | 22 | 103 | 5 | 15767678 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | MYH3 MYH6 MYH7 MYH13 RBBP4 RBBP7 MYO1B HMMR MYOF MAPK14 DST PRKAG1 MYH15 MAPK8 MAPK11 MAPK9 | 1.14e-08 | 910 | 103 | 16 | 36736316 |
| Pubmed | 2.36e-08 | 11 | 103 | 4 | 18551195 | ||
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 30685843 | ||
| Pubmed | JNK1 is required to preserve cardiac function in the early response to pressure overload. | 2.52e-08 | 3 | 103 | 3 | 16579967 | |
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 15527495 | ||
| Pubmed | Specific pathophysiological functions of JNK isoforms in the brain. | 2.52e-08 | 3 | 103 | 3 | 15673436 | |
| Pubmed | Mouse embryonic stem cells express the cardiac myosin heavy chain genes during development in vitro. | 2.52e-08 | 3 | 103 | 3 | 1694848 | |
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 18703060 | ||
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 23485395 | ||
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 24906853 | ||
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 17056565 | ||
| Pubmed | The Roles of c-Jun N-Terminal Kinase (JNK) in Infectious Diseases. | 2.52e-08 | 3 | 103 | 3 | 34502556 | |
| Pubmed | Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. | 2.52e-08 | 3 | 103 | 3 | 10797012 | |
| Pubmed | Hippocampal c-Jun-N-terminal kinases serve as negative regulators of associative learning. | 2.52e-08 | 3 | 103 | 3 | 20926661 | |
| Pubmed | JNK1 and JNK2 differently regulate IL-12 production in THP-1 macrophage cells. | 2.52e-08 | 3 | 103 | 3 | 20483637 | |
| Pubmed | JNK3 is abundant in insulin-secreting cells and protects against cytokine-induced apoptosis. | 2.52e-08 | 3 | 103 | 3 | 19609503 | |
| Pubmed | Myosin heavy chain gene expression in mouse embryoid bodies. An in vitro developmental study. | 2.52e-08 | 3 | 103 | 3 | 1939265 | |
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 15246824 | ||
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 23178455 | ||
| Pubmed | A critical role of neural-specific JNK3 for ischemic apoptosis. | 2.52e-08 | 3 | 103 | 3 | 14657393 | |
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 15474087 | ||
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 14517246 | ||
| Pubmed | Knockout of c-Jun N-terminal kinases 1, 2 or 3 isoforms induces behavioural changes. | 2.52e-08 | 3 | 103 | 3 | 23428746 | |
| Pubmed | TDRD15 MYH6 SYNE1 CCT7 MCM6 HEATR1 ACTN1 OPA1 PRDM8 SERPINB6 DST ASF1B DDX21 NOP2 ASF1A | 2.96e-08 | 844 | 103 | 15 | 25963833 | |
| Pubmed | TACE is required for fetal murine cardiac development and modeling. | 3.53e-08 | 12 | 103 | 4 | 14499647 | |
| Pubmed | 3.53e-08 | 12 | 103 | 4 | 12171600 | ||
| Pubmed | 7.10e-08 | 14 | 103 | 4 | 26724533 | ||
| Pubmed | RBBP4 RBBP7 MYO1B MCM6 HEATR1 ACTN1 URB2 MSH6 CRNKL1 DST SYNE2 DDX21 NOP2 | 7.30e-08 | 653 | 103 | 13 | 22586326 | |
| Pubmed | Phosphorylation of microtubule-associated protein tau by isoforms of c-Jun N-terminal kinase (JNK). | 1.01e-07 | 4 | 103 | 3 | 15228592 | |
| Pubmed | JNK-mediated BIM phosphorylation potentiates BAX-dependent apoptosis. | 1.01e-07 | 4 | 103 | 3 | 12818176 | |
| Pubmed | 1.01e-07 | 4 | 103 | 3 | 20525557 | ||
| Pubmed | 1.01e-07 | 4 | 103 | 3 | 9393873 | ||
| Pubmed | 1.01e-07 | 4 | 103 | 3 | 15528206 | ||
| Pubmed | A selective small-molecule inhibitor of c-Jun N-terminal kinase 1. | 1.01e-07 | 4 | 103 | 3 | 19527717 | |
| Pubmed | Replication stress interferes with histone recycling and predeposition marking of new histones. | 1.01e-07 | 4 | 103 | 3 | 20227376 | |
| Pubmed | The AP-1 repressor, JDP2, is a bona fide substrate for the c-Jun N-terminal kinase. | 1.01e-07 | 4 | 103 | 3 | 11602244 | |
| Pubmed | 1.01e-07 | 4 | 103 | 3 | 16824735 | ||
| Pubmed | 1.01e-07 | 4 | 103 | 3 | 22372722 | ||
| Pubmed | 1.01e-07 | 4 | 103 | 3 | 15693750 | ||
| Pubmed | 1.01e-07 | 4 | 103 | 3 | 10471813 | ||
| Pubmed | APP upregulation contributes to retinal ganglion cell degeneration via JNK3. | 1.01e-07 | 4 | 103 | 3 | 29238071 | |
| Pubmed | 1.01e-07 | 4 | 103 | 3 | 19596800 | ||
| Pubmed | Cortical interneurons require Jnk1 to enter and navigate the developing cerebral cortex. | 1.01e-07 | 4 | 103 | 3 | 24899703 | |
| Pubmed | 1.01e-07 | 4 | 103 | 3 | 18700144 | ||
| Pubmed | c-Jun N-terminal kinase phosphorylates DCP1a to control formation of P bodies. | 1.01e-07 | 4 | 103 | 3 | 21859862 | |
| Pubmed | RGS4 and RGS5 are in vivo substrates of the N-end rule pathway. | 1.28e-07 | 16 | 103 | 4 | 16217033 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | GNL3L RBBP7 SYNE1 CCT7 MYO1B MCM6 HEATR1 ACTN1 CPS1 CRNKL1 DST ASF1B DDX21 NOP2 ASF1A | 1.35e-07 | 949 | 103 | 15 | 36574265 |
| Pubmed | 1.68e-07 | 17 | 103 | 4 | 15572149 | ||
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 1.85e-07 | 477 | 103 | 11 | 31300519 | |
| Pubmed | Endocannabinoids affect innate immunity of Muller glia during HIV-1 Tat cytotoxicity. | 2.15e-07 | 18 | 103 | 4 | 24418364 | |
| Pubmed | MYH3 MYH6 MACC1 MYH7 MYH13 SYNE1 MYO1B HEATR1 ACTN1 ACTN3 TTC3 MFAP1 PRDM8 DST SYNE2 MYH15 ATP12A DDX21 | 2.28e-07 | 1442 | 103 | 18 | 35575683 | |
| Pubmed | The lectin jacalin induces phosphorylation of ERK and JNK in CD4+ T cells. | 2.51e-07 | 5 | 103 | 3 | 12714584 | |
| Pubmed | 2.51e-07 | 5 | 103 | 3 | 9403476 | ||
| Pubmed | 2.51e-07 | 5 | 103 | 3 | 11042694 | ||
| Pubmed | Developmental regulation of myosin gene expression in mouse cardiac muscle. | 2.51e-07 | 5 | 103 | 3 | 2277065 | |
| Pubmed | 2.51e-07 | 5 | 103 | 3 | 17192267 | ||
| Pubmed | 2.51e-07 | 5 | 103 | 3 | 9045910 | ||
| Pubmed | 2.51e-07 | 5 | 103 | 3 | 18061203 | ||
| Pubmed | 2.51e-07 | 5 | 103 | 3 | 24311790 | ||
| Pubmed | 2.51e-07 | 5 | 103 | 3 | 12225289 | ||
| Pubmed | 2.51e-07 | 5 | 103 | 3 | 14704277 | ||
| Pubmed | 2.51e-07 | 5 | 103 | 3 | 10230788 | ||
| Pubmed | 2.51e-07 | 5 | 103 | 3 | 20534829 | ||
| Pubmed | JNK regulates the photic response of the mammalian circadian clock. | 2.51e-07 | 5 | 103 | 3 | 22441692 | |
| Pubmed | 2.72e-07 | 19 | 103 | 4 | 21041952 | ||
| Pubmed | 3.94e-07 | 50 | 103 | 5 | 32068487 | ||
| Pubmed | 4.18e-07 | 21 | 103 | 4 | 25035421 | ||
| Pubmed | 5.01e-07 | 6 | 103 | 3 | 28381556 | ||
| Pubmed | 5.01e-07 | 6 | 103 | 3 | 19380828 | ||
| Pubmed | 5.01e-07 | 6 | 103 | 3 | 11884367 | ||
| Pubmed | 5.01e-07 | 6 | 103 | 3 | 27076121 | ||
| Pubmed | 5.01e-07 | 6 | 103 | 3 | 16611996 | ||
| Pubmed | 5.01e-07 | 6 | 103 | 3 | 31915148 | ||
| Pubmed | 5.01e-07 | 6 | 103 | 3 | 19647037 | ||
| Pubmed | 5.01e-07 | 6 | 103 | 3 | 11278395 | ||
| Pubmed | c-Jun N-terminal kinase 1 phosphorylates Myt1 to prevent UVA-induced skin cancer. | 5.01e-07 | 6 | 103 | 3 | 19204086 | |
| Pubmed | A new c-Jun N-terminal kinase (JNK)-interacting protein, Sab (SH3BP5), associates with mitochondria. | 5.01e-07 | 6 | 103 | 3 | 12167088 | |
| Pubmed | 5.01e-07 | 6 | 103 | 3 | 11566021 | ||
| Pubmed | 5.01e-07 | 6 | 103 | 3 | 21871441 | ||
| Pubmed | 7.36e-07 | 24 | 103 | 4 | 31581792 | ||
| Pubmed | 8.02e-07 | 339 | 103 | 9 | 30415952 | ||
| Pubmed | JNK-mediated phosphorylation of DLK suppresses its ubiquitination to promote neuronal apoptosis. | 8.75e-07 | 7 | 103 | 3 | 23979718 | |
| Pubmed | Identification of the MMS22L-TONSL complex that promotes homologous recombination. | 8.75e-07 | 7 | 103 | 3 | 21055984 | |
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 12189133 | ||
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 35210422 | ||
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 38897570 | ||
| Pubmed | HIV-1 gp120 chemokine receptor-mediated signaling in human macrophages. | 8.75e-07 | 7 | 103 | 3 | 12857973 | |
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 16819597 | ||
| Pubmed | Hyperphosphorylation of the retinoid X receptor alpha by activated c-Jun NH2-terminal kinases. | 8.75e-07 | 7 | 103 | 3 | 10383391 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | GNL3L HSP90AB4P RBBP4 SYNE1 CCT7 MYO1B MCM6 HEATR1 URB2 TTC3 OPA1 MSH6 CRNKL1 GALNT5 DDX21 NOP2 ASF1A | 9.62e-07 | 1425 | 103 | 17 | 30948266 |
| Interaction | SH3BP5 interactions | 7.34e-09 | 30 | 101 | 6 | int:SH3BP5 | |
| Interaction | H3C10 interactions | 1.26e-06 | 38 | 101 | 5 | int:H3C10 | |
| Interaction | H4C3 interactions | 5.07e-06 | 50 | 101 | 5 | int:H4C3 | |
| Interaction | H4C2 interactions | 7.45e-06 | 54 | 101 | 5 | int:H4C2 | |
| Interaction | SPANXN4 interactions | 8.16e-06 | 55 | 101 | 5 | int:SPANXN4 | |
| Interaction | H4C13 interactions | 1.06e-05 | 58 | 101 | 5 | int:H4C13 | |
| Interaction | H3C2 interactions | 2.32e-05 | 68 | 101 | 5 | int:H3C2 | |
| Interaction | H3-3B interactions | 2.35e-05 | 114 | 101 | 6 | int:H3-3B | |
| Interaction | CDK3 interactions | 2.35e-05 | 114 | 101 | 6 | int:CDK3 | |
| Interaction | CDAN1 interactions | 2.46e-05 | 34 | 101 | 4 | int:CDAN1 | |
| Interaction | MCM2 interactions | TDRD15 MYH6 RBBP4 ORC6 SYNE1 CCT7 MCM6 HEATR1 ACTN1 OPA1 PRDM8 SERPINB6 DST ASF1B PRKAG1 DDX21 ASF1A | 2.49e-05 | 1081 | 101 | 17 | int:MCM2 |
| Interaction | DUSP10 interactions | 2.87e-05 | 71 | 101 | 5 | int:DUSP10 | |
| Interaction | H3C7 interactions | 3.28e-05 | 73 | 101 | 5 | int:H3C7 | |
| Interaction | PINK1 interactions | HSP90AB4P RBBP4 RBBP7 CCT7 MYO1B MCM6 OPA1 MSH6 CRNKL1 DST ATP12A DDX21 NOP2 | 3.44e-05 | 679 | 101 | 13 | int:PINK1 |
| Interaction | OBSL1 interactions | RBBP4 SYNE1 MCM6 HEATR1 ACTN1 URB2 MFAP1 CRNKL1 CUTA MAPK14 DST SYNE2 MAPK11 DDX21 NOP2 | 4.20e-05 | 902 | 101 | 15 | int:OBSL1 |
| Interaction | H3C12 interactions | 6.31e-05 | 43 | 101 | 4 | int:H3C12 | |
| Interaction | PIH1D1 interactions | FLT4 ACTR5 CCT7 STARD7 ACTN1 CPS1 OPA1 MKS1 MFAP1 SERPINB6 GCLM DDX21 NOP2 | 7.30e-05 | 731 | 101 | 13 | int:PIH1D1 |
| Interaction | SIRT7 interactions | RBBP4 RBBP7 MYO1B MCM6 HEATR1 ACTN1 URB2 MSH6 CRNKL1 DST SYNE2 DDX21 NOP2 | 8.72e-05 | 744 | 101 | 13 | int:SIRT7 |
| Interaction | ZNF219 interactions | 8.97e-05 | 90 | 101 | 5 | int:ZNF219 | |
| Interaction | EEF1AKMT3 interactions | HSP90AB4P ERCC6L ACTR5 RHOBTB3 CCT7 MYO1B MAPK14 USP32 MAPK8 | 8.98e-05 | 364 | 101 | 9 | int:EEF1AKMT3 |
| Interaction | NCF1 interactions | 1.34e-04 | 98 | 101 | 5 | int:NCF1 | |
| Interaction | AKAP17A interactions | 1.41e-04 | 99 | 101 | 5 | int:AKAP17A | |
| Interaction | THOP1 interactions | 1.48e-04 | 100 | 101 | 5 | int:THOP1 | |
| Interaction | MYH15 interactions | 1.52e-04 | 21 | 101 | 3 | int:MYH15 | |
| Interaction | RHOBTB2 interactions | 1.83e-04 | 165 | 101 | 6 | int:RHOBTB2 | |
| Interaction | DUSP16 interactions | 1.92e-04 | 237 | 101 | 7 | int:DUSP16 | |
| Interaction | SMC3 interactions | 2.11e-04 | 408 | 101 | 9 | int:SMC3 | |
| Interaction | H4C9 interactions | 2.12e-04 | 108 | 101 | 5 | int:H4C9 | |
| Interaction | ASF1B interactions | 2.21e-04 | 109 | 101 | 5 | int:ASF1B | |
| Interaction | RAB28 interactions | 2.29e-04 | 24 | 101 | 3 | int:RAB28 | |
| Interaction | KIF20A interactions | RBBP4 RBBP7 SYNE1 APC2 MYO1B HEATR1 ACTN1 ACTN3 FAM200A CPS1 MFAP1 TEKT2 SYNE2 DDX21 NOP2 | 2.31e-04 | 1052 | 101 | 15 | int:KIF20A |
| Interaction | MAPK10 interactions | 2.82e-04 | 63 | 101 | 4 | int:MAPK10 | |
| GeneFamily | Mitogen-activated protein kinases | 5.50e-10 | 13 | 63 | 5 | 651 | |
| GeneFamily | Myosin heavy chains | 1.28e-09 | 15 | 63 | 5 | 1098 | |
| GeneFamily | Actinins | 7.14e-05 | 4 | 63 | 2 | 1112 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 7.14e-05 | 4 | 63 | 2 | 1252 | |
| GeneFamily | Lysine methyltransferases|Myb/SANT domain containing|Polycomb repressive complex 2 | 1.78e-04 | 6 | 63 | 2 | 1347 | |
| GeneFamily | SUMO specific peptidases | 2.48e-04 | 7 | 63 | 2 | 984 | |
| GeneFamily | Histone deacetylases, class I|EMSY complex|NuRD complex|SIN3 histone deacetylase complex | 4.23e-04 | 9 | 63 | 2 | 1306 | |
| GeneFamily | Histone deacetylases, class I|EMSY complex|NuRD complex|SIN3 histone deacetylase complex | 7.71e-04 | 12 | 63 | 2 | 1243 | |
| GeneFamily | PHD finger proteins|NuRD complex | 7.71e-04 | 12 | 63 | 2 | 1305 | |
| Coexpression | GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_PMA_STIM_UP | 1.10e-06 | 200 | 101 | 8 | M6356 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | RHOBTB3 MYO1B HMMR OPA1 KIFAP3 MSH6 MYOF MAPK14 DST KIN SYNE2 MAPK8 DDX21 SEC14L1 | 5.20e-06 | 856 | 101 | 14 | M4500 |
| Coexpression | BURTON_ADIPOGENESIS_PEAK_AT_16HR | 1.88e-05 | 41 | 101 | 4 | M1681 | |
| Coexpression | BURTON_ADIPOGENESIS_PEAK_AT_16HR | 2.28e-05 | 43 | 101 | 4 | MM1208 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | ERCC6L RBBP4 BZW2 ORC6 MRPL19 MCM6 HEATR1 URB2 HMMR FAM200A BRAP MSH6 METTL5 SENP6 DDX21 NOP2 TGS1 | 2.55e-05 | 1407 | 101 | 17 | M14427 |
| Coexpression | HAY_BONE_MARROW_ERYTHROBLAST | ERCC6L RBBP4 ORC6 RHOBTB3 MRPL19 CCT7 MCM6 HMMR MKS1 MSH6 MFAP1 METTL5 GCLM SLC9B2 ASF1A TGS1 | 2.77e-05 | 1271 | 101 | 16 | M39197 |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | RBBP4 MRPL19 STARD7 MCM6 URB2 HMMR MSH6 MFAP1 MPHOSPH6 DDX21 NOP2 ASF1A | 3.69e-05 | 761 | 101 | 12 | M11961 |
| Coexpression | GSE4590_PRE_BCELL_VS_LARGE_PRE_BCELL_UP | 3.70e-05 | 160 | 101 | 6 | M6863 | |
| Coexpression | WEI_MYCN_TARGETS_WITH_E_BOX | ORC6 RBBP7 MRPL19 CCT7 STARD7 URB2 HMMR OPA1 GCLM MPHOSPH6 DDX21 NOP2 | 5.42e-05 | 792 | 101 | 12 | M12113 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | GNL3L ERCC6L ORC6 DNAJC25 RHOBTB3 STARD7 HEATR1 HMMR MSH6 FAP METTL5 KIN SYNE2 TAGLN3 TSTD3 MAPK8 MAPK11 ASF1A TGS1 | 4.75e-06 | 1257 | 99 | 19 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | MGAM DOCK11 RBBP4 RHOBTB3 HMMR KIFAP3 FAP SYNE2 MAEL GALNT5 TAGLN MAPK8 SENP7 TGS1 | 2.05e-05 | 801 | 99 | 14 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | GNL3L ERCC6L ORC6 DNAJC25 RHOBTB3 STARD7 HEATR1 HMMR MSH6 FAP METTL5 KIN SYNE2 TAGLN3 TSTD3 MAPK8 MAPK11 ASF1A TGS1 | 3.85e-05 | 1459 | 99 | 19 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_vent / Disease condition, Lineage, Cell class and subclass | 4.56e-07 | 200 | 104 | 7 | 7e4c0db43a03ca11380a54f44a3cf1991e055b80 | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | 4.56e-07 | 200 | 104 | 7 | 9775ca7dedb76fcbb74f80f86b33c94e394c320a | |
| ToppCell | COVID-19-kidney-Mito-rich_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.18e-06 | 145 | 104 | 6 | afed661aef990edb8e7012ab67ace56443520c9f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-06 | 155 | 104 | 6 | 969fc4c98a96bf2f436e8e63d4deb2183ef3b864 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_bronchial_vessel-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.81e-06 | 156 | 104 | 6 | ff39712c7a2dc1b85c598d5105789aa291dea726 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.10e-06 | 160 | 104 | 6 | 830e3ef8c9708d25872c3052a0b2682fa9372111 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Proliferating_T_cell|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.68e-06 | 167 | 104 | 6 | 315cde87eed2b42a1b9b068fae94caa10ec64c70 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.68e-06 | 167 | 104 | 6 | ded4d6cccd3660662f12cf5a512de31d26325f1b | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.55e-06 | 183 | 104 | 6 | ebe369dc80c4fbf8f4dbe947147f8c47507ffb60 | |
| ToppCell | facs-Marrow-KLS-3m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.99e-06 | 192 | 104 | 6 | 03dcd9405d3d76fc7455066ba5d83c09cd17072d | |
| ToppCell | COPD-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 6.35e-06 | 194 | 104 | 6 | 8dcde77767b23e75360adb316cdccf56a00e3726 | |
| ToppCell | COVID-19-kidney-Glomerular_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.35e-06 | 194 | 104 | 6 | 660535b492445063d965095a50e1e299ce04c50a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.54e-06 | 195 | 104 | 6 | 78cfde21dde4b877fc76c8b0d5ddaabe44b912d7 | |
| ToppCell | cycling_basal_cell|World / shred by cell class for nasal brushing | 6.74e-06 | 196 | 104 | 6 | aa7bac70a2fe4a3cb28d89fa1a87c68c2ead1349 | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.74e-06 | 196 | 104 | 6 | 49cc0a2b9739abad61dff7292ea0b14d28ff35c4 | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | 6.74e-06 | 196 | 104 | 6 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 | |
| ToppCell | ASK440-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.94e-06 | 197 | 104 | 6 | 782449c522c9e16e72bf999a73090688a3aefe06 | |
| ToppCell | ASK428-Epithelial-Type_1|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.94e-06 | 197 | 104 | 6 | 9ae6661c307791c3f0ecd3d378e3d917565e5498 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.35e-06 | 199 | 104 | 6 | 101f78fe6dd1bf9e2e4dd5ad8a970312b3540927 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.35e-06 | 199 | 104 | 6 | e0fcec796afe75e42467ca86355b9fc5aa9ae0a1 | |
| ToppCell | CD8+_Memory_T_cell-CV-2|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 7.35e-06 | 199 | 104 | 6 | 1e33d8e2e0d6a54ef6e2e13f986e19fd209275a8 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.35e-06 | 199 | 104 | 6 | 14e09eaa2335d4503de50250eb4258dd5b85b304 | |
| ToppCell | 356C-Lymphocytic-NK_cells-Proliferating_NK_cell|356C / Donor, Lineage, Cell class and subclass (all cells) | 7.35e-06 | 199 | 104 | 6 | e3b69608c834bd8ce6bedde298a2763cc0d7d573 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 7.56e-06 | 200 | 104 | 6 | 84e4565d28a02700bf7f6730d1b3a58744ca0aea | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-Neuronal|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 7.56e-06 | 200 | 104 | 6 | 1decf1d2cba5ebfd3e5cd4bcd637db8f193033ce | |
| ToppCell | myeloid-pro-cDC|myeloid / Lineage and Cell class | 7.56e-06 | 200 | 104 | 6 | 4aa2308eeb94e0bdff4e02eb9e45ba8837ae14bf | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.56e-06 | 200 | 104 | 6 | b22cae282591d8dead9869c2adbb9632615f50f7 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal-Cortical_neuron|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 7.56e-06 | 200 | 104 | 6 | 19055194a5e0ea122f1b8fc62df44813f6843c95 | |
| ToppCell | LPS_anti-TNF-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.56e-06 | 200 | 104 | 6 | 1d105eeda5a2c51f9a4654ffc79b7e2348ad593b | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.56e-06 | 200 | 104 | 6 | 60d2cbf41f37f1b11eddb4c9d9246c9c1fc5a5af | |
| ToppCell | Biopsy_IPF-Immune-Proliferating_T_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 7.56e-06 | 200 | 104 | 6 | c43d1a83b2a8ad060f3d80c9438da8b7a5e307fb | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nptxr-Excitatory_Neuron.Slc17a7.Nptxr-Calb1_(Superficial_layer_pyramidal_cells--Layer_2/3)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.17e-05 | 126 | 104 | 5 | 7dcc79bf35482e8e5e5a1de7279ba080edb70522 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.63e-05 | 149 | 104 | 5 | 1328ce0104d40215ee68abfdbf74eb47b87a7b5b | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.08e-05 | 154 | 104 | 5 | 71ffc23a2e02e27cabbdbeaa622e59e9f4a4cd9d | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.08e-05 | 154 | 104 | 5 | 46155f36d3983f637b55d7525b675c8828f6ab2e | |
| ToppCell | COVID-19-kidney-Epithelial_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 3.70e-05 | 160 | 104 | 5 | 0d4880f85565d8c540c94a8f8109147b3029279a | |
| ToppCell | LPS-antiTNF-Endothelial-Mes-Like-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.41e-05 | 166 | 104 | 5 | 3b750d4023a0a09d86113aae5a97d84391f7b482 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.67e-05 | 168 | 104 | 5 | 37249f38f8f04ec5743097259de67b106ca2b02f | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.67e-05 | 168 | 104 | 5 | 96f7411474edd673b8d3ee6b8a8bb185c246daaf | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.66e-05 | 175 | 104 | 5 | a6913f992a1ea20b43e5adeca3ede3a6fda820ad | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.30e-05 | 179 | 104 | 5 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| ToppCell | COVID-19-kidney-PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.47e-05 | 180 | 104 | 5 | 493cf8d1a8f2a1ed2672f394a0338b110fd81d88 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.64e-05 | 181 | 104 | 5 | e0c46e2d52c97893e5894a51d2699e8a8a11eefc | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.64e-05 | 181 | 104 | 5 | 73b1b59810f60e3e39ca1d5073a5a0d4f5377e6e | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 6.64e-05 | 181 | 104 | 5 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo-Cycling_T|Liver / Manually curated celltypes from each tissue | 6.82e-05 | 182 | 104 | 5 | 81557cdc88777f3bd4e1dd18a760b08fc29122ef | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.00e-05 | 183 | 104 | 5 | d4aa21ba4f6f92e25ecff80b7399bca31527fd7e | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Proliferating_T_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 7.00e-05 | 183 | 104 | 5 | f03d87b556a3d50360d4eb6126b3466fe7266677 | |
| ToppCell | IIF-Lymphocyte-T_NK-T_NK_proliferative|IIF / Disease, Lineage and Cell Type | 7.18e-05 | 184 | 104 | 5 | ab8b45ce40e8c5f66e5c23332a591b4f9cba4ce1 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.18e-05 | 184 | 104 | 5 | 4b864c74e2cf7e58d6bd151f955c43d72f035d52 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.37e-05 | 185 | 104 | 5 | 9d424a8608b339dd6129c58d87626678d4ec4af7 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.37e-05 | 185 | 104 | 5 | 4d0f3d86fab02c80093e62cb0c79c586c13c5412 | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_mature-endo_bronchial_(8)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.56e-05 | 186 | 104 | 5 | 0cc7504297fd0c97ea50e4b3ff58fcedc4c1cfaa | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_cycling-endo_proliferating2_(14)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.56e-05 | 186 | 104 | 5 | 2cbf1aaff87cd9fba01f814a119fe86e5af82290 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.95e-05 | 188 | 104 | 5 | 319fbeca200ab998daf49fcaee0bfdb57bf7ee4b | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.15e-05 | 189 | 104 | 5 | 45b9d00a4968fb22207d95228cdcf022afe1e50b | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+VCAM1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.15e-05 | 189 | 104 | 5 | c121817ddad164e9cfe382c43d0cbc9215508d02 | |
| ToppCell | facs-Marrow-KLS-3m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.15e-05 | 189 | 104 | 5 | 533685a921a65d84107d8d33c43b4fffde019143 | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.15e-05 | 189 | 104 | 5 | 8382d331e01e83591ba9c8ea83edbf2436c18b17 | |
| ToppCell | PBMC-Mild-cDC_12|Mild / Compartment, Disease Groups and Clusters | 8.15e-05 | 189 | 104 | 5 | 946c95d2ecc36b241f58e8c4ad6455fe47c762fa | |
| ToppCell | facs-Marrow-KLS-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.15e-05 | 189 | 104 | 5 | dca56ab02bf0505f9a352ff907edaef30906d854 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.15e-05 | 189 | 104 | 5 | 1d660bceee449aebf12fc9af4c74af246837b27a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 8.15e-05 | 189 | 104 | 5 | a48df46274d51e84ffb40264646de7346104efb9 | |
| ToppCell | droplet-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.35e-05 | 190 | 104 | 5 | e80d66ba0d5c263e94c1ab0b89d1dc7b837af3e1 | |
| ToppCell | droplet-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.35e-05 | 190 | 104 | 5 | f32d66c0e74e0a2a23ecb857c4daf0d8573a806c | |
| ToppCell | facs-Marrow-KLS-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.35e-05 | 190 | 104 | 5 | a513c1e7df62c28128c932a68b252ee8f0255172 | |
| ToppCell | droplet-Lung-18m-Endothelial-lymphatic_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.35e-05 | 190 | 104 | 5 | b79ffd05806244a9790cd04c66fb4f92c824e69f | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.35e-05 | 190 | 104 | 5 | f50b9814a1beac67dc042a8c27dfd085ceeda3a6 | |
| ToppCell | PBMC-Severe-cDC_12|Severe / Compartment, Disease Groups and Clusters | 8.35e-05 | 190 | 104 | 5 | 84ee185939bdefb10705b621a70da27701eadcee | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.35e-05 | 190 | 104 | 5 | a22a510b4a257eb0eaf09c7ae7978d3d2f07a58c | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.35e-05 | 190 | 104 | 5 | c0ee404d705b0b4f0c6ded4d070ad85eac4b16db | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.35e-05 | 190 | 104 | 5 | 57c136bf6d7feafb4a220877bed0cc8fdf314db2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.56e-05 | 191 | 104 | 5 | 912e2d10d3423aa7f708fcf2b11da1845f12d7d3 | |
| ToppCell | facs-Marrow-KLS-18m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.56e-05 | 191 | 104 | 5 | 51327ba28b2e3052087fa0fc9b7c0339dc09a1e3 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.56e-05 | 191 | 104 | 5 | 77a2746b6d9c53b08d4405411c16fcc5a6c734ce | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 8.56e-05 | 191 | 104 | 5 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic-lymphocyte-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.56e-05 | 191 | 104 | 5 | 56b45259dfc38bd5ea43b0e3adf47e7e2c043a5d | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.77e-05 | 192 | 104 | 5 | 27ff3621e177e7932dd44dd6baa81551ea75a874 | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_cycling-endo_proliferating2_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.77e-05 | 192 | 104 | 5 | ac3d87aa301d30515c369bd7fc16f33b82173a85 | |
| ToppCell | RA-09._Endothelium_I|RA / Chamber and Cluster_Paper | 8.77e-05 | 192 | 104 | 5 | 8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Endothelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.77e-05 | 192 | 104 | 5 | a42aed9e563f5f4af029b8804c104f11ad227a8f | |
| ToppCell | facs-Thymus-Flowthrough-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.77e-05 | 192 | 104 | 5 | e8d47504b744040a762ec9b670a66cc060b2ae86 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.99e-05 | 193 | 104 | 5 | ffa1932da2979d7b63dbac32eb5788346a3f5b2a | |
| ToppCell | Severe_COVID-19-Myeloid-proliferating_Myeloid_cells|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 8.99e-05 | 193 | 104 | 5 | 0d85025690c9cd545cba30abc38acbdd6a39b153 | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_cycling-endo_proliferating3_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.99e-05 | 193 | 104 | 5 | f7e4a390921780587b9bd084e495e646fa1ec74f | |
| ToppCell | ILEUM-inflamed-(8)_Smooth_muscle_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.99e-05 | 193 | 104 | 5 | 084c88f08ce0ecd6c9f4334caed370eb2154f896 | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-proliferating|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.99e-05 | 193 | 104 | 5 | f20b90e3f3f5c9a1ae51c5ebe6d3adb954a142f2 | |
| ToppCell | RV-09._Endothelium_I|World / Chamber and Cluster_Paper | 8.99e-05 | 193 | 104 | 5 | e3fa47e2c7cd8a5b69186711c57751f2296de8ae | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Paneth|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.21e-05 | 194 | 104 | 5 | 2f6e62a4ec8707bd5a16c0734c5131af55207ea2 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.21e-05 | 194 | 104 | 5 | f39a471293ecc5c5967b00e772b8f48ebc9affbe | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.21e-05 | 194 | 104 | 5 | cb39850e9577015b6b9834e98c36b412bae7d462 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.21e-05 | 194 | 104 | 5 | 408597c9aa302a44b112c1d612c21fbb0227a82a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.21e-05 | 194 | 104 | 5 | 04bfc555743f7d8821439d05ae442d15e9886c59 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.21e-05 | 194 | 104 | 5 | 193cc20fefbd795a4ad59e401a95af47d30603e7 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.21e-05 | 194 | 104 | 5 | 2360b5f995b360419de41612368cab9fb61781a1 | |
| ToppCell | RV-09._Endothelium_I|RV / Chamber and Cluster_Paper | 9.21e-05 | 194 | 104 | 5 | 7b408096e717f2327c12aea35a8d5fc4621d3b06 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.21e-05 | 194 | 104 | 5 | 903ae11708b0cb24538c6982abd57fe6fa95b8d3 | |
| ToppCell | Control-Lymphoid_T/NK-T/NK_proliferative|Control / Disease group, lineage and cell class | 9.21e-05 | 194 | 104 | 5 | 9bbb124001fba7450f4639f47f9b720a483e7242 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.21e-05 | 194 | 104 | 5 | 590a9d4f054e6a3685daf752c9354650fcc7d18a | |
| ToppCell | BAL-Severe-Myeloid-Myeloid|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.21e-05 | 194 | 104 | 5 | 58406502a8cbcc3037f79a1b6a683df408297ae5 | |
| Drug | Ambotz208527-57-5 | 8.77e-09 | 17 | 100 | 5 | CID010258704 | |
| Drug | satratoxin H | 1.21e-08 | 7 | 100 | 4 | CID000434380 | |
| Drug | methyldiazonium ion | 2.42e-08 | 8 | 100 | 4 | CID000115287 | |
| Drug | SC68376 | 4.34e-08 | 9 | 100 | 4 | CID000005174 | |
| Drug | benzothiazol-2-ylacetonitrile | 8.22e-08 | 3 | 100 | 3 | CID000342465 | |
| Drug | formycin triphosphate | 9.47e-08 | 51 | 100 | 6 | CID000122274 | |
| Drug | NSC339663 | 1.55e-07 | 250 | 100 | 10 | CID000003892 | |
| Drug | SB220025 | 1.61e-07 | 29 | 100 | 5 | CID000005164 | |
| Drug | NSC 402447 | 1.77e-07 | 93 | 100 | 7 | CID006437335 | |
| Drug | purealin | 2.08e-07 | 58 | 100 | 6 | CID006419303 | |
| Drug | K00039 | 2.71e-07 | 32 | 100 | 5 | CID009549277 | |
| Drug | SB-242235 | 3.39e-07 | 14 | 100 | 4 | CID009863367 | |
| Drug | SB202474 | 3.39e-07 | 14 | 100 | 4 | CID000005162 | |
| Drug | pyridinyl imidazole | 5.00e-07 | 36 | 100 | 5 | CID000005171 | |
| Drug | LBH589 | 5.27e-07 | 109 | 100 | 7 | CID006918837 | |
| Drug | blebbistatin | 8.04e-07 | 116 | 100 | 7 | CID003476986 | |
| Drug | AC1MJ5N7 | 8.17e-07 | 5 | 100 | 3 | CID003086135 | |
| Drug | procymidone | 8.61e-07 | 40 | 100 | 5 | CID000036242 | |
| Drug | LY294002 | IL12B MYH3 MYH6 MYH7 FLT4 MYH13 ACTN1 FANCB MAPK14 TAGLN MAPK8 MAPK11 MAPK9 MAPK10 MSLN | 9.23e-07 | 748 | 100 | 15 | CID000003973 |
| Drug | piribedil | 1.10e-06 | 42 | 100 | 5 | CID000004850 | |
| Drug | K-Cl | MGAM MYH3 MYH6 MYH7 FLT4 MYH13 MYO1B BRAP MAPK14 MAPK8 MAPK11 MAPK9 MAPK10 | 1.21e-06 | 567 | 100 | 13 | CID000004873 |
| Drug | Thr-Gly | 1.29e-06 | 19 | 100 | 4 | CID006427013 | |
| Drug | AC1L1B3Z | 1.57e-06 | 45 | 100 | 5 | CID000001273 | |
| Drug | indole-5-carboxamide | 1.63e-06 | 6 | 100 | 3 | ctd:C514526 | |
| Drug | celiprolol | 1.96e-06 | 47 | 100 | 5 | CID000002663 | |
| Drug | DENSPM | 2.18e-06 | 48 | 100 | 5 | CID000004282 | |
| Drug | AC1L3ZTY | 2.84e-06 | 7 | 100 | 3 | CID000098120 | |
| Drug | Cp-38 | 2.84e-06 | 7 | 100 | 3 | CID006918286 | |
| Drug | fludelone | 2.84e-06 | 7 | 100 | 3 | CID006918712 | |
| Drug | ICI 182,780 | 3.20e-06 | 272 | 100 | 9 | CID000104741 | |
| Drug | celecoxib | 3.30e-06 | 273 | 100 | 9 | CID000002662 | |
| Drug | SKF86002 | 3.48e-06 | 24 | 100 | 4 | CID000005228 | |
| Drug | oridonin | 3.94e-06 | 54 | 100 | 5 | CID000034378 | |
| Drug | trapidil | 5.16e-06 | 57 | 100 | 5 | CID000005531 | |
| Drug | S-(-)-Etomoxir | 5.27e-06 | 100 | 100 | 6 | CID000060765 | |
| Drug | AC1L1CFC | 5.63e-06 | 58 | 100 | 5 | CID000001874 | |
| Drug | K00085 | 5.69e-06 | 27 | 100 | 4 | CID009549283 | |
| Drug | AC1NDZBN | 5.69e-06 | 27 | 100 | 4 | CID004634037 | |
| Drug | CEP-1347 | 6.13e-06 | 59 | 100 | 5 | CID000133005 | |
| Drug | juzentaihoto | 6.77e-06 | 9 | 100 | 3 | ctd:C063587 | |
| Drug | S 52 | 6.77e-06 | 9 | 100 | 3 | CID000023681 | |
| Drug | AC1L6EKE | 6.77e-06 | 9 | 100 | 3 | CID000265720 | |
| Drug | NSC226080 | IL12B MYH3 MYH6 MYH7 FLT4 MYH13 MCM6 BRAP MAPK14 PRKAG1 MAPK8 MAPK11 MAPK9 MAPK10 | 8.11e-06 | 782 | 100 | 14 | CID000005040 |
| Drug | D-JNKI-1 | 9.65e-06 | 10 | 100 | 3 | ctd:C478085 | |
| Drug | irisolidone | 9.65e-06 | 10 | 100 | 3 | CID005281781 | |
| Drug | CGP57380 | 1.01e-05 | 31 | 100 | 4 | CID011644425 | |
| Drug | BIRB796 | 1.07e-05 | 66 | 100 | 5 | CID000156422 | |
| Drug | hexitol | 1.20e-05 | 243 | 100 | 8 | CID000000453 | |
| Drug | B0683 | 1.30e-05 | 117 | 100 | 6 | CID006398969 | |
| Drug | AC1NURR2 | 1.32e-05 | 11 | 100 | 3 | CID005490351 | |
| Drug | 9-CP-Ade | 1.32e-05 | 11 | 100 | 3 | CID000012852 | |
| Drug | SR144528 | 1.43e-05 | 70 | 100 | 5 | CID003081355 | |
| Drug | quinolone | 1.47e-05 | 34 | 100 | 4 | CID000006038 | |
| Drug | Trifluoperazine | 1.65e-05 | 35 | 100 | 4 | ctd:D014268 | |
| Drug | sesamolin | 1.76e-05 | 12 | 100 | 3 | CID000101746 | |
| Drug | anthrapyrazole | 1.76e-05 | 12 | 100 | 3 | CID000119330 | |
| Drug | Kinome_3024 | 1.91e-05 | 2 | 100 | 2 | CID011539329 | |
| Drug | Kinome_3019 | 1.91e-05 | 2 | 100 | 2 | CID011658882 | |
| Drug | Kinome_3025 | 1.91e-05 | 2 | 100 | 2 | CID011715520 | |
| Drug | Kinome_3027 | 1.91e-05 | 2 | 100 | 2 | CID011640926 | |
| Drug | Kinome_3028 | 1.91e-05 | 2 | 100 | 2 | CID011590363 | |
| Drug | AC1L1JYL | 2.14e-05 | 434 | 100 | 10 | CID000005262 | |
| Drug | SCIO-469 | 2.28e-05 | 13 | 100 | 3 | ctd:C499748 | |
| Drug | Cytotoxins | 2.28e-05 | 13 | 100 | 3 | ctd:D003603 | |
| Drug | AC1LADJ6 | 2.37e-05 | 130 | 100 | 6 | CID000486032 | |
| Drug | NSC407322 | 2.48e-05 | 131 | 100 | 6 | CID000003977 | |
| Drug | 2-butyl-6-methoxyphenol | 2.65e-05 | 197 | 100 | 7 | CID011954184 | |
| Drug | farnesylamine | 2.89e-05 | 14 | 100 | 3 | CID006449783 | |
| Drug | 5-((4-methylphenyl)methylene)-2-(phenylamino)-4(5H)-thiazolone | 2.89e-05 | 14 | 100 | 3 | ctd:C503119 | |
| Drug | Naproxen [22204-53-1]; Up 200; 17.4uM; HL60; HT_HG-U133A | 2.92e-05 | 200 | 100 | 7 | 1869_UP | |
| Drug | arsenate | 2.93e-05 | 135 | 100 | 6 | CID000000233 | |
| Drug | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole | 3.19e-05 | 137 | 100 | 6 | ctd:C090942 | |
| Drug | ethyl acetate | 3.19e-05 | 137 | 100 | 6 | CID000008857 | |
| Drug | AC1L9LMC | 3.27e-05 | 83 | 100 | 5 | CID000448113 | |
| Drug | methyl methanesulfonate | 3.27e-05 | 364 | 100 | 9 | CID000004156 | |
| Drug | fast white | 3.45e-05 | 42 | 100 | 4 | CID000024008 | |
| Drug | E-4IB | 3.60e-05 | 15 | 100 | 3 | CID000123372 | |
| Drug | methyl 3-hydroxyimino-11-oxoolean-12-en-28-oate | 3.60e-05 | 15 | 100 | 3 | ctd:C587228 | |
| Drug | phthalazine | 3.60e-05 | 15 | 100 | 3 | CID000009207 | |
| Drug | Ro 31 | 3.75e-05 | 141 | 100 | 6 | CID000214797 | |
| Drug | lapatinib | 3.88e-05 | 86 | 100 | 5 | CID000208908 | |
| Drug | C11102 | 3.88e-05 | 86 | 100 | 5 | CID000443069 | |
| Drug | SM-2 | 4.11e-05 | 87 | 100 | 5 | CID000486033 | |
| Drug | dracorhodin | 4.42e-05 | 16 | 100 | 3 | ctd:C060327 | |
| Drug | ICE inhibitor | 4.56e-05 | 146 | 100 | 6 | CID000004330 | |
| Drug | alpha-ketoisovalerate | 4.58e-05 | 89 | 100 | 5 | CID000000049 | |
| Drug | helenalin | 4.58e-05 | 89 | 100 | 5 | CID000023205 | |
| Drug | AC1L1KMJ | 4.68e-05 | 476 | 100 | 10 | CID000030956 | |
| Drug | vanadium | 5.10e-05 | 149 | 100 | 6 | CID000023990 | |
| Drug | dracorhodin | 5.35e-05 | 17 | 100 | 3 | CID000069509 | |
| Drug | N-glyceryl-2-hexyl-3-keto-capramide | 5.71e-05 | 3 | 100 | 2 | CID011645877 | |
| Drug | CGC 11093 | 5.71e-05 | 3 | 100 | 2 | ctd:C515676 | |
| Drug | Calebin-A | 5.71e-05 | 3 | 100 | 2 | CID000637429 | |
| Drug | NSC364150 | 5.88e-05 | 48 | 100 | 4 | CID000100771 | |
| Drug | AC1L1IZ2 | 5.92e-05 | 304 | 100 | 8 | CID000004795 | |
| Drug | AC1L1JM9 | 5.92e-05 | 304 | 100 | 8 | CID000005103 | |
| Drug | 3-nonenal | 6.39e-05 | 18 | 100 | 3 | CID005283336 | |
| Drug | NSC363979 | 6.39e-05 | 18 | 100 | 3 | CID000183413 | |
| Drug | sorafenib | 7.07e-05 | 158 | 100 | 6 | CID000216239 | |
| Drug | CdCl2 | 7.26e-05 | 98 | 100 | 5 | CID000024947 | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 1.00e-10 | 10 | 100 | 5 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 1.00e-10 | 10 | 100 | 5 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 1.00e-10 | 10 | 100 | 5 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 1.00e-10 | 10 | 100 | 5 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 1.00e-10 | 10 | 100 | 5 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 1.00e-10 | 10 | 100 | 5 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 1.00e-10 | 10 | 100 | 5 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 1.00e-10 | 10 | 100 | 5 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 3.14e-10 | 12 | 100 | 5 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 3.14e-10 | 12 | 100 | 5 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 5.09e-10 | 13 | 100 | 5 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 1.18e-09 | 15 | 100 | 5 | DOID:0050646 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 6.16e-07 | 48 | 100 | 5 | DOID:423 (implicated_via_orthology) | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 1.31e-06 | 7 | 100 | 3 | C0751337 | |
| Disease | cardiomyopathy (implicated_via_orthology) | 4.41e-06 | 71 | 100 | 5 | DOID:0050700 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 7.94e-06 | 80 | 100 | 5 | DOID:12930 (implicated_via_orthology) | |
| Disease | colorectal carcinoma (is_implicated_in) | 5.55e-05 | 22 | 100 | 3 | DOID:0080199 (is_implicated_in) | |
| Disease | Cardiomyopathy, Familial Hypertrophic, 1 (disorder) | 6.79e-05 | 4 | 100 | 2 | C3495498 | |
| Disease | Hypertrophic cardiomyopathy 1 | 6.79e-05 | 4 | 100 | 2 | cv:C3495498 | |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 6.79e-05 | 4 | 100 | 2 | cv:CN293514 | |
| Disease | Caveolinopathy | 6.79e-05 | 4 | 100 | 2 | cv:C5679790 | |
| Disease | CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1 | 6.79e-05 | 4 | 100 | 2 | 192600 | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 1.13e-04 | 5 | 100 | 2 | C1450051 | |
| Disease | focal segmental glomerulosclerosis 1 (implicated_via_orthology) | 1.13e-04 | 5 | 100 | 2 | DOID:0111128 (implicated_via_orthology) | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 1.13e-04 | 5 | 100 | 2 | C0410190 | |
| Disease | Emery-Dreifuss muscular dystrophy | 1.69e-04 | 6 | 100 | 2 | cv:C0410189 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 1.69e-04 | 6 | 100 | 2 | C0410189 | |
| Disease | Cholestasis, Extrahepatic | 1.74e-04 | 32 | 100 | 3 | C0005398 | |
| Disease | Parkinson's disease (implicated_via_orthology) | 2.00e-04 | 157 | 100 | 5 | DOID:14330 (implicated_via_orthology) | |
| Disease | Idiopathic hypertrophic subaortic stenosis | 2.36e-04 | 7 | 100 | 2 | C0700053 | |
| Disease | atrioventricular septal defect (implicated_via_orthology) | 2.36e-04 | 7 | 100 | 2 | DOID:0050651 (implicated_via_orthology) | |
| Disease | Obstructive asymmetric septal hypertrophy | 2.36e-04 | 7 | 100 | 2 | C0597124 | |
| Disease | Cardiomyopathy, Hypertrophic, Familial | 4.03e-04 | 9 | 100 | 2 | C0949658 | |
| Disease | Muscular dystrophy, limb-girdle, autosomal dominant | 5.03e-04 | 10 | 100 | 2 | cv:C5675009 | |
| Disease | osteosarcoma (is_marker_for) | 6.13e-04 | 11 | 100 | 2 | DOID:3347 (is_marker_for) | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 7.34e-04 | 12 | 100 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | Trigeminal Neuralgia | 7.34e-04 | 12 | 100 | 2 | C0040997 | |
| Disease | thyroid gland carcinoma (is_marker_for) | 7.34e-04 | 12 | 100 | 2 | DOID:3963 (is_marker_for) | |
| Disease | Secondary Trigeminal Neuralgia | 7.34e-04 | 12 | 100 | 2 | C0393787 | |
| Disease | Trigeminal Neuralgia, Idiopathic | 7.34e-04 | 12 | 100 | 2 | C0393786 | |
| Disease | Cardiomyopathies | 1.02e-03 | 130 | 100 | 4 | C0878544 | |
| Disease | pancreatic adenocarcinoma (is_implicated_in) | 1.16e-03 | 15 | 100 | 2 | DOID:4074 (is_implicated_in) | |
| Disease | pancreatic ductal carcinoma (is_implicated_in) | 1.32e-03 | 16 | 100 | 2 | DOID:3587 (is_implicated_in) | |
| Disease | nucleotide measurement | 1.98e-03 | 73 | 100 | 3 | EFO_0010513 | |
| Disease | behavioural disinhibition measurement | 2.14e-03 | 75 | 100 | 3 | EFO_0006946 | |
| Disease | myocardial infarction (biomarker_via_orthology) | 2.18e-03 | 160 | 100 | 4 | DOID:5844 (biomarker_via_orthology) | |
| Disease | Primary familial hypertrophic cardiomyopathy | 2.51e-03 | 22 | 100 | 2 | cv:C0949658 | |
| Disease | autoimmune disease | 2.89e-03 | 173 | 100 | 4 | EFO_0005140 | |
| Disease | Hypertrophic obstructive cardiomyopathy | 3.24e-03 | 25 | 100 | 2 | C4551472 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ELKEDIVERLWIYID | 61 | Q14146 | |
| EDDELIREVYEYWIK | 166 | Q9H2F5 | |
| DVLSEEAILKWYKEA | 371 | Q9Y6E2 | |
| IYELEEHKIETWREV | 106 | P54619 | |
| IYWENKIVRIEKDTA | 421 | Q7Z569 | |
| MEDYEKLASDLLEWI | 276 | P12814 | |
| IEDLSEDLEWKIIYV | 31 | Q9Y294 | |
| IYEWKGKIEEDSEVL | 106 | O60888 | |
| KEWVSELQYRIKLDE | 266 | A6NHR8 | |
| YWEELENLVQSKKIV | 146 | P48507 | |
| LDTWKIYVEFIDDIV | 901 | Q96DT5 | |
| IEEDIKKIYDEATWL | 416 | B6SEH9 | |
| ILEEKEISRILETYW | 786 | O60423 | |
| DDNEVWITRKEYEEK | 546 | Q9H9F9 | |
| EDDIWVTKLAYLSDI | 336 | Q8TCP9 | |
| LEQEEYKKEGIEWTF | 496 | P12883 | |
| EIEEEKKRTARTDYW | 266 | O60870 | |
| EHAIEEWKELIYKEV | 346 | P45984 | |
| SELVNWYLKEIESEI | 746 | Q14566 | |
| WYLKEIESEIDSEEE | 751 | Q14566 | |
| VAEWEKYIISLADRD | 491 | P23467 | |
| ERTLEEWKELTYQEV | 331 | Q15759 | |
| NDEEEYEAWKVRELK | 271 | P55081 | |
| SDWALLREEEKEKYA | 41 | Q96JY0 | |
| ERRVWLEEKEKVIEY | 601 | O60299 | |
| EKSWEIDLKQLEYLI | 191 | P17735 | |
| DEREHTIEEWKELIY | 381 | P53779 | |
| LEEEFEWLKKSEVLY | 146 | Q9UHH9 | |
| DLLIDEWKSLTYDEV | 331 | Q16539 | |
| ELIWLNEKEEEEVAY | 711 | Q03001 | |
| KEDQTEYLEERWVKE | 161 | Q58FF6 | |
| EYLEERWVKEVVKKH | 166 | Q58FF6 | |
| LRVEWEKDYVNDLKD | 901 | P54707 | |
| YTVEWSIKIRDEEKI | 1846 | O43451 | |
| TIDLEEQKLYWADAK | 201 | O75197 | |
| IEEDIKKIYDEVTWL | 416 | B6SEH8 | |
| EHTIEEWKELIYKEV | 346 | P45983 | |
| EWKELIYKEVMDLEE | 351 | P45983 | |
| IDESLIFYKKWELEA | 311 | Q13421 | |
| YNEEEKKWEGVLREI | 586 | Q2TBA0 | |
| YHETLEWLKEEKRRD | 366 | P52701 | |
| VAIWELKKDVYVVEL | 21 | P29460 | |
| AVEERVINEEYKIWK | 11 | Q09028 | |
| VEERVINEEYKIWKK | 11 | Q16576 | |
| SEQLVEKIWYRVIDD | 471 | Q8NB91 | |
| ELTEEINKWRLLYEE | 571 | O75330 | |
| EWKIKIDIIAELRYD | 171 | Q9NRN9 | |
| WEIDEYIDFEKIRKA | 141 | O60313 | |
| RDDIVQLKEAYKWIT | 176 | Q3MIT2 | |
| ETFLKRELWIKENYE | 306 | Q9H1X3 | |
| LLNEIEKEEKEKLWY | 141 | O95996 | |
| SEALADDLEWKIIYV | 31 | Q9NVP2 | |
| LVEKSVTGWKEIEYE | 621 | P31327 | |
| EVLWKSYIDFEIEQE | 676 | Q9BZJ0 | |
| DELVEVYTDVKHRWK | 166 | Q13609 | |
| LWKAERYEIISEISK | 1706 | Q5JSL3 | |
| SIRYWEQEVSELKKD | 296 | P0C221 | |
| VRVAEVWLDEYKELF | 746 | Q7Z7M9 | |
| QLELQKIEWEKELYD | 686 | Q3MJ40 | |
| LVSEKVYDWKVLADV | 656 | Q6ZN28 | |
| EWYEVLKIAADILIK | 571 | Q9H583 | |
| QLELQKIEWEKELYD | 686 | A2RUR9 | |
| SYAWKELKEQLGEEI | 651 | Q9NR30 | |
| ELENEDLKLWTETIY | 511 | Q92503 | |
| SKKFLWEELELVREE | 141 | P0C7I6 | |
| TLDIIAEYDEEWAKK | 656 | Q92845 | |
| VWDYVILDEAHKIKT | 221 | Q2NKX8 | |
| AFQWEELEEDIRKKL | 351 | O94955 | |
| YLEVEWEVKLKTHRQ | 956 | Q9BQF6 | |
| HEEEKSYLWRLEKEE | 191 | O00635 | |
| EYNEMLELILKWIEK | 5531 | Q8NF91 | |
| ELKQEWKFVSEEIER | 3466 | Q8WXH0 | |
| KYDADLENKLVDWII | 21 | Q9UI15 | |
| FLKYLDAVWEVEILV | 1666 | B5MCY1 | |
| LEEEEKKIISEEHWY | 31 | Q99547 | |
| EEHWYLDLPELKEKE | 41 | Q99547 | |
| FVLEQEEYKKESIEW | 506 | Q9Y2K3 | |
| DLVPKEVVEKWLDYL | 176 | Q9NVN8 | |
| AKDEELLVWYGKELT | 121 | Q9NQV8 | |
| EKAEVEKIIAVAWDI | 381 | Q86UD5 | |
| KELTYEKFVEWTRLD | 246 | P35237 | |
| YSELKWQEKNTLEEI | 276 | Q9UIF3 | |
| IVDAEWNILYDKLEK | 266 | Q99832 | |
| VLEQEEYKKEGIEWT | 496 | P11055 | |
| EDLTQDYEEWKRKIL | 226 | Q9Y5N6 | |
| KYDEELEERLVEWII | 21 | Q01995 | |
| KETWYDLEEVLLEEM | 466 | Q14563 | |
| VLEQEEYKKEGIEWT | 496 | P13533 | |
| VEENEWVVDYALKKR | 521 | P46087 | |
| EEYEKLASELLEWIR | 291 | Q08043 | |
| LVKTYSLEEESIWKE | 311 | Q5SQS8 | |
| REYDTSKIEAAIWKE | 271 | P49406 | |
| EEIKKLEVDEITLWY | 506 | Q12884 | |
| CEDERIYTLKEIVEW | 176 | Q8N1K5 | |
| DIKEEEKSYQVIRWF | 66 | Q6NUS8 | |
| ELLQKEYKVELDLWL | 281 | P0CB48 | |
| IETEGEKQELWKYTI | 251 | Q9NXB0 | |
| LIDEEEEEKLYEQWK | 341 | Q5VZP5 | |
| WYKDERLLEEKSGVD | 711 | P35916 | |
| EVSVLENWKESEVYK | 1641 | P53804 | |
| FVLEQEEYKKEGIEW | 496 | Q9UKX3 | |
| LREYLEVEWEVKKGS | 991 | Q9GZR1 | |
| EDYWIELENIKKSSE | 76 | Q8N392 | |
| KWDALVIKLEVIERD | 191 | Q9NQZ5 | |
| LIDVREIWEILEYQK | 46 | H0UI37 | |
| KKYLDEIVQESWRKE | 131 | Q96RS0 | |
| LEESDIIDLEKRYWL | 191 | Q8NFA0 | |
| KEEQEEYIREDIEWT | 421 | O43795 | |
| WLKLIDEVIEDTRYT | 691 | Q9NZM1 |